SCHEMBL491830

SCHEMBL491830

C=C(CCCCC(C)C)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.44
KDM4A O75164 1/20 0.44
PHF8 Q9UPP1 1/20 0.44
KDM2A Q9Y2K7 1/20 0.44
BLM P54132 1/20 0.41
CA1 P00915 2/20 0.38
TBXAS1 P24557 2/20 0.38
LTA4H P09960 1/20 0.37
LMNA P02545 1/20 0.37
KDM1A O60341 1/20 0.36
TET2 Q6N021 3/20 0.35
TET3 O43151 1/20 0.35
TET1 Q8NFU7 1/20 0.35
GRIK1 P39086 1/20 0.34
GRIK2 Q13002 1/20 0.34
GRM1 Q13255 1/20 0.34
GRM2 Q14416 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14936541 0.98 KDM4C (0.47) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL10788708 0.98 KDM4C (0.47) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL138197 0.98 KDM4C (0.47) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL1026046 0.98 KDM4C (0.47) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL26700 0.98 KDM4C (0.47) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL24391 0.98 KDM4C (0.47) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL513804 0.98 KDM4C (0.47) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL8647496 0.98 KDM4C (0.47) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL920756 0.98 KDM4C (0.47) KDM4CKDM4APHF8KDM2ABLM
SCHEMBL98991 0.98 KDM4C (0.47) KDM4CKDM4APHF8KDM2ABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728339-B1 COMPOSITION FOR OPHTHALMOLOGICAL PRODUCTS AMO Ireland (IE) 2022-07-06 EP claimed
EP-3398988-B1 METHOD FOR OBTAINING A COLLOIDAL DISPERSION, COLLOIDAL DISPERSION AND USE THEREOF COMPANHIA NITRO QUIM BRASILEIRA (BR) 2020-12-09 EP claimed
EP-1730097-B2 PREPARATION OF STERICALLY HINDERED HYDROXYPHENYLCARBOXYLIC ACID ESTERS SI GROUP INC (US) 2019-07-24 EP claimed
EP-1730097-B1 PREPARATION OF STERICALLY HINDERED HYDROXYPHENYLCARBOXYLIC ACID ESTERS SI GROUP INC (US) 2016-06-22 EP claimed
US-9046515-B2 Polymer compound for medical material, and biochip substrate using the polymer compound SUMITOMO BAKELITE COMPANY, LTD. (JP) 2015-06-02 US claimed
EP-1802726-B1 PHOTOCHROMIC COMPOUNDS COMPRISING POLYMERIC SUBSTITUENTS AND METHODS FOR PREPARATION AND USE THEREOF ADVANCED POLYMERIK PTY LTD (AU) 2011-11-30 EP claimed
EP-0779304-B1 HYDROLYZABLE METAL-CONTAINING RESIN AND ANTIFOULING PAINT COMPOSITION NIPPON PAINT CO LTD (JP) 2000-04-12 EP claimed
EP-0781198-B1 MULTILAYER ADHESIVE CONSTRUCTION WITH ONE BARRIER LAYER AVERY DENNISON CORP (US) 1998-06-17 EP claimed
US-20240217976-A2 COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2024-07-04 US disclosed
CN-112980543-B High viscosity index comb polymer viscosity modifiers and methods of using the same to alter lubricant viscosity 英菲诺姆国际有限公司 2023-12-19 CN disclosed
CN-112980549-B High viscosity index comb polymer viscosity modifiers and methods of using the same to alter lubricant viscosity 英菲诺姆国际有限公司 2023-12-15 CN disclosed
EP-3839018-B1 HIGH VISCOSITY INDEX COMB POLYMER VISCOSITY MODIFIERS AND METHODS OF MODIFYING LUBRICANT VISCOSITY USING SAME INFINEUM INT LTD (GB) 2023-10-18 EP disclosed
US-20230265314-A1 RESIN COMPOSITION AND DISPLAY APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-24 US disclosed
EP-3839019-B1 HIGH VISCOSITY INDEX COMB POLYMER VISCOSITY MODIFIERS AND METHODS OF MODIFYING LUBRICANT VISCOSITY USING SAME INFINEUM INT LTD (GB) 2023-08-02 EP disclosed
US-20080050584-A1 IMPACT-ABSORBING PRESSURE-SENSITIVE ADHESIVE SHEET AND METHOD OF PRODUCING THE SAME NITTO DENKO CORPORATION (JP) 2008-02-28 US disclosed
WO-2006053772-A1 METHOD AND COMPOSITION FOR CLEANING PLASTIC SURFACES CONTAINING HALOGENATED POLYMERS BAERLOCHER GMBH (DE) 2006-05-26 WO disclosed
EP-1446432-B1 COPOLYMERS CONTAINING FLUORINE, METHOD FOR THE PRODUCTION AND USE THEREOF HENKEL KGAA (DE) 2006-05-10 EP disclosed
EP-1446432-A2 COPOLYMERS CONTAINING FLUORINE, METHOD FOR THE PRODUCTION AND USE THEREOF Henkel Kommanditgesellschaft auf Aktien (DE) 2004-08-18 EP disclosed
US-6677047-B2 BENZOTRIAZOLE COMPOUND HAVING A VINYL GROUP MODIFIED THROUGH ITS HYDROXY GROUP WITH A SILANE COMPOUND; TRANSPARENT COATINGS FOR POLYCARBONATE SUBSTRATES WITH MAR, WEATHER, AND CHEMICAL RESISTANCE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2004-01-13 US disclosed
WO-2003033557-A2 COPOLYMERS CONTAINING FLUORINE, METHOD FOR THE PRODUCTION AND USE THEREOF HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240217976-A2 COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND RAD51, MDM2, UBE2D3 KDM4C 3760/4885KDM4A 3532/4885PHF8 2392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.